Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 3, 2008, Pages 245-249

  Madani, H ^a   Hettiaratchy, S ^b   Clarke, A ^a   Butler, P E M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Composite tissue transplantation; Face transplantation; Immunosuppression; Tolerance

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CD3 ANTIBODY; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAD; DEOXYSPERGUALINE; EVEROLIMUS; FINGOLIMOD; FK 779; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; PREDNISOLONE; RAPAMYCIN; RECEPTOR ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADRENAL SUPPRESSION; ALLOTRANSPLANTATION; ASEPTIC NECROSIS; AVASCULAR NECROSIS; BACTERIAL INFECTION; BODY FAT DISTRIBUTION; CADAVER; CATARACT; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EXPERIENCE; FACE SURGERY; FRACTURE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HUMERAL ATROPHY; HYPERLIPIDEMIA; HYPERNATREMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MEDICAL INFORMATION; METHODOLOGY; MYCOSIS; NEOPLASM; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PEPTIC ULCER; PLASTIC SURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; RECIPIENT; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SKIN ATROPHY; SKIN CULTURE; VIRUS INFECTION; WATER RETENTION;

FACIAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN; TISSUE TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 38949200998     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2007.10.048     Document Type: Review

References (55)

1. Butler P.E., Clarke A., and Hettiaratchy S. Facial transplantation. A new option in reconstruction of severe facial injury. BMJ 331 (2005) 1349-1350
2. Devauchelle B., Badet L., Lengele B., et al. First human face allograft: early report. Lancet 368 (2006) 203-209
3. Macartney J. Face transplant for bear attack victim. Times (Lond) (April 15, 2006). http://www.timesonline.co.uk/article/0, 25689-2135297, 00.html (accessed Sept 21, 2006)
4. Hettiaratchy S., and Butler P.E. Extending the boundaries of transplantation. BMJ 326 (2003) 1226-1227
5. Hettiaratchy S., Randolph M.A., Petite F., et al. Composite tissue allotransplantation: a new era in plastic surgery?. Br J Plast Surg 57 (2004) 381-391
6. Clarke A., and Butler P.E. Facial transplantation: adding to the reconstructive options after severe facial injury and disease. Expert Opin Biol Ther 5 (2005) 1539-1546
7. Hettiaratchy S., and Butler P.E. Facial transplantation - fantasy or the future?. Lancet 360 (2002) 5-6
8. Butler P.E., Hettiaratchy S., and Clarke A. Managing the risks of facial transplantation. Lancet 368 (2006) 561-563
9. Brouha P., Naidu D., Cunningham M., et al. Risk acceptance in composite-tissue allotransplantation reconstructive procedures. Microsurgery 26 (2006) 144-149 discussion 149-50
10. Lee W.P.A., Yaremchuk M.J., Pan Y.C., et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 87 (1991) 401-411
11. Gorantla V.S., Barker J.H., Jones J.W., et al. Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies. Microsurgery 20 (2000) 420-429
12. Cendales L., and Hardy M.A. Immunological considerations in composite tissue transplantation: overview. Microsurgery 20 (2002) 412-419
13. In: Rubin R.H., and Young L.S. (Eds). Clinical Approach to Infection in the Immunocompromised Host. 3rd ed. (1994), Plenum Press, New York
14. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 338 (1998) 1741-1751
15. Shapiro R., Fung J.J., Jain A.B., et al. The side effects of FK 506 in humans. Transplant Proc 264 (1990) 63-67
16. Sratta R.J., and for the FK/MMF Multi-Center Study Group. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. Transplant Proc 29 (1997) 654-655
17. Gander B., Brown C.S., and Vasilic D. Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery. Transpl Int 19 (2006) 868-880
18. Schulak J.A. Steroid immunosuppression in kidney transplantation: a passing era. J Surg Reas 117 (2004) 154-162
19. Veenstra D.L., Best J.H., and Hornberger J. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 33 (1999) 829-839
20. Clavijo-Alvarez J.A., Hamad G.G., Taieb A., et al. Pharmacologic approaches to composite tissue allograft. J Hand Surg 32 (2007) 104-118
21. First M.R., and Peddi V.R. Malignancies complicating organ transplantation. Transplant Proc 30 (1998) 2768-2770
22. Sheil A.G.R., Disney A.P.S., Mathew T.H., et al. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CsA) or AZA/CsA. Transplant Proc 23 (1991) 1111-1112
23. Baumeister S., Kleist C., Dohler B., et al. Risks of allogeneic hand transplantation. Microsurgery 24 (2004) 98-103
24. Jones N.F. Concerns about human hand transplantation in the 21st century. J Hand Surg [Am] 27 (2002) 771-787
25. Brenner M.J., Tung T.H., Jensen J.N., et al. The spectrum of complications of immunosuppression: is the time right for hand transplantation?. J Bone Joint Surg Am 84 (2002) 1861-1870
26. Cecka J.M., and Terasaki P.I. The UNOS Scientific Renal Transplant Registry. In: Terasaki P.I., and Cecka J.M. (Eds). Clinical Transplants 1994 (1994), UCLA Tissue Typing Laboratory, Los Angeles 1-18
27. Tejani A., and Sullivan E.K. The impact of acute rejection on chronic rejection: a report of the North American Paediatric Renal Transplant Cooperative Study. Paediatr Transplant 4 (2000) 107-111
28. Kahan B.D. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction. Transplantation 71 (2001) S52-S57
29. Krieger N.R., and Emre S. Novel immunosuppressants. Paediatr Transplant 8 (2004) 594-599
30. Lima R.S., Nogueira-Martins M.F., Silva Jr. H.T., et al. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination. Transplant Proc 36 (2004) 1015-1017
31. Kahan B.D. Sirolimus: a ten-year perspective. Transplant Proc 36 (2004) 71-75
32. Ayrout C., Lanzetta M., Chunasuwankul R., et al. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime. Transplant Proc 36 (2004) 669-674
33. Ringe B., Braun F., Lorf T., et al. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. Transplant Proc 30 (1998) 1415-1416
34. Fujita T., Takahashi S., Yagihashi A., et al. Prolonged survival of rat skin allograft by treatment with FK506 ointment. Transplantation 64 (1997) 922-925
35. Gruber S.A., Shirbacheh M.V., Jones J.W., et al. Local drug delivery to composite tissue allografts. Microsurgery 20 (2000) 407-411
36. Kawai T., Cosimi A.B., Colvin R.B., et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59 (1995) 256-262
37. Schwarze M.L., Menard M.T., Fuchimoto Y., et al. Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine. Ann Thorac Surg 70 (2000) 131-139
38. Huang C., Fuchimoto Y., Scheier-Dolberg R., et al. Stable mixed-chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 105 (2000) 173-181
39. Lee W.P., Rubin J.P., Bourget J.L., et al. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens. Plast Reconstr Surg 107 (2001) 1482-1490 discussion 1491-2
40. Butler P.E., Lee W.P., van de Water A.P., et al. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression. Plast Reconstr Surg 105 (2000) 2424-2430 discussion 2431-2
41. Cober S.R., Randolph M.A., and Lee W.P. Skin allograft survival following intrathymic injection of donor bone marrow. J Surg Res 85 (1999) 204-208
42. Tai C., Goldenberg M., Schuster K.M., et al. Composite tissue allotransplantation. J Inv Surg 16 (2003) 193-201
43. Hettiaratchy S., Melendy E., Randolph M.A., et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 77 (2004) 514-521
44. Seimionow M., Ortak T., Izycki D., et al. Induction of tolerance in composite-tissue allografts. Transplantation 74 (2002) 1211-1217
45. Siemionow M., Zieliniski M., Ozmen S., et al. Intraosseus transplantation of donor-derived hematopoietic stem and progenitor cells induces donor-specific chimerism and extends composite tissue allograft survival. Transplantation Proc 37 (2005) 2303-2308
46. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
47. Siemionow M., and Agaoglu G. Tissue transplantation in plastic surgery. Clin Plastic Surg 34 (2007) 251-269
48. Kanitakis J., Jullien D., Petruzzo P., et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 76 (2003) 688-693
49. Lanzetta M., Petruzzo P., Vitale G., et al. Human hand transplantation: what have we learned?. Transplant Proc 36 (2004) 664-668
50. Stark G.B., Swartz W.M., Narayanan K., et al. Hand transplantation in baboons. Transplant Proc 19 (1987) 3968-3971
51. Hovius S.E.R., Stevens H.P.J.D., and Van Nierop P.W.M. Allogenic transplantation of the radial side of the hand in the rhesus monkey. Plast Reconstr Surg 89 (1992) 700-709
52. Petit F., Minns A.B., Dubernard J.M., et al. Composite tissue allotransplantation and reconstructive surgery: first clinical applications. Ann Surg 11 (2003) 1-6
53. Dubernard J.M., Burloux G., Giraux P., et al. Three lessons learned from the first double hand transplantation. Bull Acad Natl Med 186 (2002) 1051-1062
54. Dubernard J.M., Owen E., Herzberg G., et al. Human hand allograft: report on first 6 months. Lancet 353 (1999) 1315-1320
55. Selvaggi G., Levi D.M., Kato T., et al. Expanded use of transplantation techniques: abdominal wall transplantation and intestinal autotransplantation. Transplant Proc 36 (2004) 1561-1563